Effects of rosiglitazone on the serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes

Basit Öğe Kaydı
dc.contributor.authorAtamer, A.
dc.contributor.authorSelek, S.
dc.contributor.authorKocyigit, Y.
dc.contributor.authorIlhan, N.
dc.contributor.authorSen, T.
dc.contributor.authorAtamer, Y.
dc.date.accessioned2026-08-12T16:59:14Z
dc.date.issued2007
dc.departmentFırat Üniversitesi
dc.description76th Congress of the European-Atherosclerosis-Society -- JUN 10-13, 2007 -- Helsinki, FINLAND
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean Atherosclerosis Soc
dc.identifier.doi10.1016/S1567-5688(07)71699-9
dc.identifier.endpage185
dc.identifier.issn1567-5688
dc.identifier.issue1
dc.identifier.orcid0000-0003-1235-3957
dc.identifier.startpage184
dc.identifier.urihttps://doi.org/10.1016/S1567-5688(07)71699-9
dc.identifier.urihttps://hdl.handle.net/11508/47254
dc.identifier.volume8
dc.identifier.wosWOS:000247869100747
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofAtherosclerosis Supplements
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleEffects of rosiglitazone on the serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu